PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
54.18%
Revenue growth above 1.5x 6203.T's 16.23%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
46.39%
Gross profit growth above 1.5x 6203.T's 17.91%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
84.64%
EBIT growth 75-90% of 6203.T's 101.30%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
62.55%
Operating income growth under 50% of 6203.T's 201.82%. Michael Burry would be concerned about deeper cost or sales issues.
70.19%
Net income growth at 50-75% of 6203.T's 99.47%. Martin Whitman would question fundamental disadvantages in expenses or demand.
70.18%
EPS growth at 50-75% of 6203.T's 99.28%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
70.18%
Diluted EPS growth at 50-75% of 6203.T's 99.28%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.00%
Share reduction while 6203.T is at 0.10%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6203.T is at 0.10%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.46%
10Y revenue/share CAGR above 1.5x 6203.T's 1.05%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1.20%
Positive 5Y CAGR while 6203.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-10.83%
Negative 3Y CAGR while 6203.T stands at 15.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 6203.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-214.80%
Negative 10Y net income/share CAGR while 6203.T is at 549.40%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-184.42%
Negative 5Y net income/share CAGR while 6203.T is 350.23%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-167.39%
Negative 3Y CAGR while 6203.T is 2150.99%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
363.18%
10Y equity/share CAGR above 1.5x 6203.T's 40.50%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
45.89%
Positive 5Y equity/share CAGR while 6203.T is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
13.94%
3Y equity/share CAGR above 1.5x 6203.T's 1.99%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.03%
Firm’s AR is declining while 6203.T shows 6.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.92%
We show growth while 6203.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.17%
Asset growth above 1.5x 6203.T's 1.15%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.05%
We have a declining book value while 6203.T shows 2.79%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.90%
Debt growth far above 6203.T's 5.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
12.70%
R&D growth of 12.70% while 6203.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
3.92%
We expand SG&A while 6203.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.